Barely Significant
← all excerpts

Efficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis.

Urol Res Pract · 2026 · PMC13242081 · PMID 42364198

Europe PMCDOI
1
hedged sentence
0.0490
closest p · 1.0× alpha
0.0490
boldest claim

The sentences

slightly significantP = .049actually significant
Regarding relapse after 1 month follow-up posttreatment, 10.7% of the mirabegron group suffered from relapse compared to 22.7% in the desmopressin group, with a slightly significant difference, P = .049* ( Table 2 ).

also in 1,762 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.